Delivery Order SPE2DB22D1017-SPE2DB25FG1MS
Award Date
4/30/25
Potential Completion Date
5/21/25
Potential Value
$3.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of 4,565,833,079 units of PROQUAD vaccine vials. The $3,203.98 firm fixed price contract has an ultimate completion date of October 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between AmerisourceBergen and DLA Troop Support Medical for the comprehensive supply of pharmaceutical and medical...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4,565,772,992 PROQUAD vaccine vials. The fixed-price contract has a ceiling value of $1,570.54 and an ultimate completion date of October 1, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a range of...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for 4,563,910,641 PROQUAD VIALS. The delivery order has a completion date of March 27, 2024 and a potential value of $2,557.96. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 from DLA, which serves as the primary vehicle for the company to provide...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PROQUAD vaccine vials. The contract has a ceiling value of $6,407.96 and a completion date of May 31, 2024. It is a firm fixed-price contract with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4,568,032,217 units of the PROQUAD VIALS pharmaceutical product. The contract has a ceiling value of $3,308.68 and a period of performance through May 13, 2025. The award was made on April 22, 2025 and does not utilize any set-aside designations, indicating open competition. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that holds a...
This firm-fixed-price delivery order contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,100 PROQUAD VIALS. The contract has a ceiling value of $3,141.08 and an ultimate completion date of November 1, 2024. It is not associated with any set-aside program. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the delivery of PROQUAD vials, a pharmaceutical product, with a potential value of $4,159.95 and a completion date of March 12, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of PROQUAD VIALS, a pharmaceutical product, with a ceiling value of $1,601.99 and a performance period through April 11, 2024. This delivery order is part of a larger indefinite delivery contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,376,885 units of the PROQUAD vaccine. The contract has a ceiling value of $4,159.95 and is a Firm Fixed Price arrangement with a period of performance through November 29, 2024. The contract was not set aside for any specific business type. Amerisourcebergen holds a broader $999,999,999 Indefinite Delivery Contract with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PROQUAD VIALS. The contract has a total ceiling value of $1,687.48 and is a firm fixed-price, non-set-aside contract with a performance period through May 16, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...